Adaptive Hemorrhage Control Systems for Specialized Environments
Legal Citation
Summary of the Inventive Concept
An innovative hemorrhage control system designed for high-security, disaster relief, and extreme weather conditions, providing enhanced adaptability and effectiveness in unique operational environments.
Background and Problem Solved
The original patent, 'Automated retrievable hemorrhage control system', addressed the critical issue of catastrophic bleeding from large and medium size vessels. However, the system's design and functionality may not be optimal for specific, high-stress environments. This new inventive concept addresses the limitations of the original patent by adapting the hemorrhage control system for specialized markets, ensuring improved performance and reliability in extreme conditions.
Detailed Description of the Inventive Concept
The adaptive hemorrhage control system comprises a stent graft device, a balloon, and optional sensors and heating/cooling elements. In high-security environments, the system is designed for rapid deployment and secure bleeding control. For disaster relief operations, the system is optimized for percutaneous access site deployment and rapid bleeding control. In extreme weather conditions, the system incorporates heating or cooling elements to maintain a predetermined temperature during deployment. The system's components work in tandem to provide effective bleeding control, even in challenging environments.
Novelty and Inventive Step
The new claims introduce novel adaptations for high-security, disaster relief, and extreme weather conditions, providing a non-obvious and innovative solution for hemorrhage control in specialized environments. The inventive step lies in the system's adaptability to unique operational environments, ensuring improved performance and reliability.
Alternative Embodiments and Variations
Alternative embodiments of the adaptive hemorrhage control system could include variations in stent graft material, balloon design, and sensor configurations. Additionally, the system could be integrated with other medical devices or technologies to enhance its functionality and effectiveness.
Potential Commercial Applications and Market
The adaptive hemorrhage control system has significant commercial potential in the medical device industry, particularly in the areas of emergency medicine, disaster relief, and high-security medical operations. The system's adaptability and effectiveness in unique operational environments make it an attractive solution for medical professionals and organizations operating in these specialized markets.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/958 |
| A | A61 | A61B5/02 |
| A | A61 | A61B5/02042 |
| A | A61 | A61B5/6862 |
| A | A61 | A61B17/12036 |
| A | A61 | A61B17/12045 |
| A | A61 | A61B17/12109 |
| A | A61 | A61B17/12118 |
| A | A61 | A61B17/12136 |
| A | A61 | A61F2/07 |
| A | A61 | A61B5/024 |
| A | A61 | A61B5/02055 |
| A | A61 | A61B5/02158 |
| A | A61 | A61B5/14539 |
| A | A61 | A61B5/14542 |
| A | A61 | A61B5/6853 |
| A | A61 | A61B2017/00017 |
| A | A61 | A61B2017/00022 |
| A | A61 | A61F2/9522 |
| A | A61 | A61F2002/061 |
| A | A61 | A61F2002/077 |
| A | A61 | A61F2002/9528 |
| A | A61 | A61F2230/0067 |
| A | A61 | A61F2230/0069 |
| A | A61 | A61F2250/001 |
| A | A61 | A61F2250/0002 |
| A | A61 | A61F2250/0003 |
| A | A61 | A61F2250/0024 |
| A | A61 | A61F2250/0039 |
| A | A61 | A61F2250/0059 |
| A | A61 | A61F2250/0069 |
| A | A61 | A61F2250/0096 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Endovascular medical devices and hemorrhage control systems, involving interventional radiology, medical device design, and emergency medical technologies. Requires expertise in vascular anatomy, medical device engineering, and minimally invasive surgical techniques.
Person of Ordinary Skill (PHOSITA) Profile
A medical device engineer or interventional radiologist with advanced degree, 5-10 years experience in vascular intervention technologies, familiar with stent graft designs, balloon deployment mechanisms, and emergency medical device adaptations
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core hemorrhage control technology. The disclosed adaptations for high-security, disaster relief, and extreme environments represent standard design modifications that would be apparent to a skilled practitioner seeking to optimize the base stent graft technology for specific operational contexts.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,443 |
|---|---|
| Title | Automated retrievable hemorrhage control system |
| Assignee(s) | Board of Regents of the University of Nebraska |